Cognitive Drug Insights
Mark discusses the potential of using low doses of dopamine agonists to enhance working memory in healthy individuals, emphasizing their safety and the surprising lack of awareness participants have regarding their cognitive improvements. He highlights the need for a shift in focus from disease-centric approaches to understanding cognition, noting that neurotransmitter systems often work in combination rather than isolation, which presents challenges for research and pharmaceutical development.In this clip
From this podcast
Huberman Lab
Dr. Mark D'Esposito: How to Optimize Cognitive Function & Brain Health
Related Questions